• Please log in or register to access this feature.

Review

You have free access to this content

Nonalcoholic fatty liver disease: Definitions, risk factors, and workup†

  1. Puneet Puri M.B.B.S., M.D.,
  2. Arun J. Sanyal M.B.B.S., M.D.*

Article first published online: 25 SEP 2012

DOI: 10.1002/cld.81

Issue

Clinical Liver Disease

Clinical Liver Disease

Special Issue: Non-alcoholic Fatty Liver Disease

Volume 1, Issue 4, pages 98–102, September 2012

Additional Information

How to Cite

Puri, P. and Sanyal, A. J. (2012), Nonalcoholic fatty liver disease: Definitions, risk factors, and workup. Clinical Liver Disease, 1: 98–102. doi: 10.1002/cld.81

Author Information

  1. Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University, Richmond, VA

*Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University, P.O. Box 98034, Richmond, VA 23298

  1. †

    Potential conflict of interest: Nothing to report.

Publication History

  1. Issue published online: 25 SEP 2012
  2. Article first published online: 25 SEP 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (506K)

References

  • 1
    Brunt EM. Histological assessment of nonalcoholic fatty liver disease in adults and children. Clin Liver Dis 2012; 1: 108-111.
  • 2
    Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012; 142: 1592-1609.
  • 3
    Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-1419.
  • 4
    Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-2474.
    Direct Link:
  • 5
    Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321.
    Direct Link:
  • 6
    Brunt EM, Kleiner DE, Wilson L, Belt P, Neuschwander-Tetri BA; for NASH Clinical Research Network. The NAS and the histopathologic diagnosis of NASH: distinct clinicopathologic meanings. Hepatology 2011; 53: 810-820.
    Direct Link:
  • 7
    Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-1231.
  • 8
    Kleiner DE, Brunt EM. Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research. Semin Liver Dis 2012; 32: 3-13.
  • 9
    Noureddin M, Loomba R. Nonalcoholic fatty liver disease: indications for liver biopsy and noninvasive biomarkers. Clin Liver Dis 2012; 1: 104-107.
View Full Article (HTML) Get PDF (506K)